EMILY SULLIVAN: Open Payments
NPI 1750787123 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 86 payments from 19 companies in 2025. Trend: 2023 $678 · 2024 $1,014 · 2025 $1,690
Food & beverage: $1,690
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 17 | $352 |
| UCB, Inc. | 15 | $228 |
| Incyte Corporation | 12 | $198 |
| ABBVIE INC. | 5 | $127 |
| PFIZER INC. | 5 | $112 |
| Janssen Biotech, Inc. | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Galderma Laboratories, L.P. | 4 | $82 |
| Amgen Inc. | 3 | $73 |
| GENZYME CORPORATION | 3 | $62 |
Products named: Zoryve, Bimzelx, OPZELURA, SKYRIZI, CIBINQO, TREMFYA, COSENTYX, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
